Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2019
Committee Review
Floor Vote
Governor
Introduced Jan 22, 2019
Last action Apr 1, 2019
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
6
Key actions
2
Committee
2
Mar 13, 2019
Lower · Passed
Committee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
lower
Mar 11, 2019
Lower · Passed
Committee report, to adopt as amended and re-refer to Health and Human Services Policy
lower
Jan 22, 2019
Introduced
Introduction and first reading, referred to Commerce
lower
1 primary · 14 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Laurie Halverson
DDemocratic-Farmer-Labor
Co
Alice Mann
DDemocratic-Farmer-Labor
Co
Diane Loeffler
DDemocratic-Farmer-Labor
Co
Hunter Cantrell
DDemocratic-Farmer-Labor
Co
Jeff Brand
DDemocratic-Farmer-Labor
Co
Jennifer Schultz
DDemocratic-Farmer-Labor
Co
John Huot
DDemocratic-Farmer-Labor
Co
John Persell
DDemocratic-Farmer-Labor
Co
Mary Kunesh-Podein
DDemocratic-Farmer-Labor
Co
Mike Howard
DDemocratic-Farmer-Labor
Co
Raymond Dehn
DDemocratic-Farmer-Labor
Ask Maddy
·
AI policy assistant
Ask Maddy about HF 284
Scope: MN
Hi! I can help you understand HF 284. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline